CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (11,379,604)	$ (2,237,248)
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on disposal of fixed assets	3,712	594
Depreciation and amortization	784,701	128,318
Stock-based compensation	3,320,681	264,389
Stock issued in exchange for professional services	2,907,000	297,500
Paycheck protection program loan forgiveness	(108,532)
Changes in assets and liabilities:
Accounts receivable	(193,348)	65,833
Inventories	(912,683)	62,778
Prepaid expenses and other assets	(523,638)	3,626
Accounts payable	622,825	100,921
Accrued expenses and other liabilities	(1,452,158)	7,052
Contract liabilities	253,323	(136,682)
Net cash used in operating activities	(6,677,721)	(1,442,919)
CASH FLOW FROM INVESTING ACTIVITIES:
Notes receivable	(200,000)
Purchases of fixed assets	(225,642)	(70,086)
Acquisition of MicaSense	(14,536,863)
Acquisition of Measure	(14,916,850)
Platform development costs	(762,881)
Net cash used in investing activities	(30,642,236)	(70,086)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from promissory note		107,439
Issuance of Series E Preferred stock		1,010,000
Repurchase of Series E Preferred stock		(1,110,880)
Sales of Common stock, net of issuance cost	37,182,646	22,796,743
Sale of Common stock from exercise of warrants	8,305,368	2,637,723
Exercise of stock options	113,168	47,400
Net cash provided by financing activities	45,601,182	25,488,425
Net increase in cash	8,281,225	23,975,420
Cash at the beginning of the year	23,940,333	717,997
Cash at the end of the period	32,221,558	24,693,417
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest cash paid
Income taxes paid
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Conversion of Series B, C, D and E Preferred stock into Common stock		6,551
Deemed dividends		7,884,207
Liability related to MicaSense acquisition	5,000,000
Liability related to Measure acquisition	5,625,000
Stock consideration for MicaSense acquisition	3,000,000
Stock consideration for Measure acquisition	$ 24,375,000